Madras High Court Grants Injunction Against Three Pharma Firms Over Trademark Infringement of ARG-9

In a significant move for pharmaceutical intellectual property protection, the High Court of Judicature at Madras has granted an ad-interim injunction against three pharmaceutical companies. Presided over by Justice K. Kumaresh Babu, the order restricts the respondents from utilizing the trademark "ORG-9," which the Court found prima facie identical to the applicant’s registered mark.

The Conflict Over Alpha-Numeric Branding

The dispute arose when Nouveau Medicament Private Limited, a Chennai-based pharmaceutical entity, approached the Court alleging trademark infringement, passing off, and unfair competition. The applicant holds the registered trademark "ARG-9" (Registration No. 2645507). They contended that three Haryana-based firms—Orange Biotech Private Limited, Ritual Drugs Private Limited, and Akshar Molecules Inc—were manufacturing and distributing similar medical products under the label "ORG-9."

Legal Arguments and Judicial Scrutiny

Represented by counsel Mr. MS Bharath, the applicant argued that the respondents' use of "ORG-9" was deceptively similar to their established brand. The primary concern raised was the potential for market confusion among consumers and healthcare providers, given that both companies operate within the same pharmaceutical sector and utilize near-identical alpha-numeric branding.

The Court reviewed the filings and noted the striking similarity in the nomenclature, noting that the only distinction between the two marks was the arrangement of letters surrounding the digit 9.

Key Observations

In reaching its decision, the Court drew a direct parallel to its previous rulings concerning similar branding disputes. Justice K. Kumaresh Babu observed:

  • "The applicant is the registered trademark holder of a pharmaceutical product."
  • "The respondent... is also a manufacturer of a similar product with a trademark ‘ORG-9’."
  • "In a similar situation... this Court... had found that the alpha-numeric mark, namely ‘URG-9’, was prima facie infringing the trademark of the applicant."
  • "This Court is also prima facie convinced that there has been an infringement of the trademark of the applicant."

Implications of the Ruling

The Madras High Court has issued an order of injunction, restraining the respondents, their agents, and associated entities from manufacturing, selling, or advertising any products under the "ORG-9" mark or any other mark deceptively similar to "ARG-9."

This decision reinforces the high threshold for trademark distinctiveness in the pharmaceutical industry, where the potential for confusion carries significant health and safety implications. The respondents have been served notice, with the matter set for further hearing in four weeks. This ruling serves as a stern reminder to companies regarding the sanctity of registered intellectual property and the risks associated with adopting confusingly similar trade names in a competitive market.